Thanks for your valid points and views , appreciated as you have History here..
Look I don't want to sound like a Trader ,,,, but I can assure Current SH SNT has been flying under the radar (that's not a cliche) I recall PXS as many others I talk with do but then it just seemed to all go deaf ,,, SNT was Phoenixed but the SNT profile just seemed low ,, others will attest to this..
Now I understand that SNT and Gary might want to remain Humble?? or are quiet achievers? are playing by the old school rulebook "The Data Will Speak for Itself and us" well those days are gone..
Companies now require a structured release strategy with Editorial that's already delivered under embargo to the Investment Sites..
Ground work needs to be applied surrounding awareness and the approaching data (notice I didn't use the word Imminent) ......
The wider market should know that Phase II data is on the near term horizon ,,that the Company is nearing an inflection point , there should be an air of anticipation and excitement... that merits the 6/7 years of Drug Development...
SNT is fast approaching the deal zone,,, I have to agree with the above posters,, Management want a Payday,, a Phase III Funding Round is prohibitive.
The Company has already had companies identify that they have interest..
I have no doubt that the Company is about to enter a comprehensive rerate but again as mentioned above SNT SH deserve the increase in SH Value to be maximised and that takes coordinated Effort....
I will be content to see 12.5c SP anything less and I will be disappointed ... NZT
Thanks Savvy , I couldn't get your reply to sit up top with ajk???
Expand
